MedTrace Logo

Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa

NCT02344498 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 7350

Last updated 2024-11-15

No results posted yet for this study

Summary

Viral hepatitis kills nearly one million people each year, even though effective treatment exists. The aim of this study is to establish a treatment protocol for hepatitis B, which is simple and cheap enough to be implemented in resource-limited settings.

Conditions

Interventions

DRUG

Tenofovir disoproxil

Sponsors & Collaborators

  • Addis Ababa University

    collaborator OTHER

  • The Research Council of Norway

    collaborator OTHER

  • University of Agder

    collaborator OTHER

  • South-Eastern Norway Regional Health Authority, Norway

    collaborator UNKNOWN

  • St. Paul's Hospital Millennium Medical College, Ethiopia

    collaborator OTHER

  • Haramaya University,Ethiopia

    collaborator UNKNOWN

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Asgeir Johannessen, MD PhD · Oslo University Hospital

  • Nega Berhe, MD PhD · Addis Abeba University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Ethiopia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02344498 on ClinicalTrials.gov